VISA / VRSA: Vancomycin-Intermediate/Resistant Staphylococcus aureus

Data & Statistics about VISA / VRSA

The following are CDC publications or publications with CDC authors reporting key data and statistics about VISA/VRSA.

Publications

• Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, U.S., 1997-2001. CID 2003
• Public Health Dispatch: Vancomycin-Resistant Staphylococcus aureus- Pennsylvania, 2002. MMWR October 2002
• Staphylococcus aureus Resistant to Vancomycin, U.S. 2002 MMWR July 2002
• Vancomycin-intermediate and resistant Staphylococcus aureus: what the infectious disease specialist needs to know. CID 2001
• Emergence of vancomycin resistance in Staphylococcus aureus. NEJM 1999
• Vancomycin-Intermediate Staphylococcus aureus in a Home Health-Care Patient. EID Journal 2001
• Staphylococcus aureus with Reduced Susceptibility to Vancomycin---Illinois, 1999.. MMWR 2000
• Staphylococcus aureus with Reduced Susceptibility to Vancomycin Isolated from a Patient with Fatal Bacteremia. EID Journal 1999
• Update: Staphylococcus aureus with Reduced Susceptibility to Vancomycin - U.S., 1997. MMWR 1997. PDF(265 KB/24 pages)
• Staphylococcus aureus with Reduced Susceptibility to Vancomycin - U.S., 1997. MMWR 1997. PDF(273 KB/24 pages)
• Reduced Susceptibility of Staphylococcus aureus to Vancomycin - Japan 1996.MMWR 1997. PDF(864 KB/3 pages)

Infection Control Topics

• Infection Control Home
• Healthcare-Associated Infections
• Protecting Patients
• Protecting Healthcare Workers
• Infection Control Guidelines
• Infection Control A-Z
• About DHQP